The studies on cystatin B deficient mice: neurochemical and behavioural alterations in animal model of progressive myoclonus epilepsy of Unverricht–Lundborg type

dc.contributor.authorVaarmann, Annika
dc.date.accessioned2007-08-21T12:06:28Z
dc.date.available2007-08-21T12:06:28Z
dc.date.issued2007-08-21T12:06:28Z
dc.description.abstractThe study aimed to further characterize the neurochemical and behavioural phenotype of cystatin B deficient mice, which are the animal model of progressive myoclonus epilepsy of Unverricht–Lundborg type. Cystatin B deficiency provokes impairment in glutamatergic neuronal circuits and enhances tryptophan metabolism along kynurenine and serotonin pathways in the brain of mutant mice. Observed neurochemical alterations may contribute to the pathological mechanisms and might have a causal impact to the formation of neurological phenotype seen in diseased humans. Käesolevas uurimuses kirjeldatakse täpsemalt Unverricht-Lundborgi tüüpi müokloonilise epilepsia mudellooma tsüstatiin B geeni puudulikkusega hiire neurokeemilist ja käitumuslikku fenotüüpi. Leitud muutused mutantsete hiirte aju trüptofaani metabolismis ning erutus– ja pidurdusnärviringete omavahelises tasakaalus võivad mõjutada müokloonilisele epilepsiale iseloomuliku haiguspildi väljakujunemist ning selgitada patoloogilisi mehhanisme inimesel.et
dc.identifier.urihttp://hdl.handle.net/10062/3377
dc.language.isoenet
dc.titleThe studies on cystatin B deficient mice: neurochemical and behavioural alterations in animal model of progressive myoclonus epilepsy of Unverricht–Lundborg typeet
dc.title.alternativeTsüstatiin B puudulikkusega kaasnevate neurokeemiliste ning käitumuslike muutuste uurimus Unverricht-Lundborgi tüüpi progresseruva müokloonilise epilepsia loommudeliset
dc.typeThesiset

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
vaarmann_annika.pdf
Size:
1.92 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
373 B
Format:
Item-specific license agreed upon to submission
Description: